Arrhythmogenic right ventricular dysplasia is a classic form of chronic myocardial disease with a broad phenotypical spectrum. We report an atypical case of a patient with biventricular arrhythmogenic cardiomyopathy. Although the current diagnosis criteria are the most widely accepted ones, they focus solely on the right ventricular phenotype. The use of late gadolinium enhancement in cardiac magnetic resonance in this patient was essential for the diagnosis and assessment of the left ventricular involvement extent. This tool allows a broader use of current diagnosis criteria for this disease.
Introduction
Arrhythmogenic right ventricular dysplasia / cardiomyopathy (ARVD) consists of the classic form of a chronic, progressive and hereditary myocardial disease that has a broad phenotypic spectrum. 1 The use of the broader term "arrhythmogenic cardiomyopathy" (AC) is now accepted, which also encompasses the variants involving either mainly the left ventricle (LV) or the LV and the right ventricle (RV) -the latter, usually understood as a later form of the disease. 1 The incidence of this disease is 1:2,000 to 1:5,000, and the mean age at diagnosis is approximately 30 years old, constituting an important cause of sudden cardiac death. 2, 3 We report on a patient with ARVD and concomitant LV involvement.
Case report
A 57-year-old male patient with irregular follow-up at a cardiology clinic for 15 years due to complaints of palpitations at exertion was assessed. He only had a history of systemic arterial hypertension, medicated and controlled with bisoprolol and lisinopril, with no other significant personal history or family history. The most recent electrocardiographic exams showed sinus rhythm, left anterior hemiblock pattern, premature ventricular contractions with complete left bundle branch block (LBBB) and superior axis, as well as periods of nonsustained ventricular tachycardia.
The previous complementary examinations included a 24-hour Holter monitoring with a non-sustained ventricular tachycardia (VT) episode with LBBB configuration, with very frequent polymorphic premature ventricular contractions (136/hr). The patient had been submitted to a transthoracic echocardiogram performed 3 years earlier, showing slight impairment of LV systolic function (ejection fraction of 47% according to the biplane Simpson's method) and diffuse hypokinesia; dilated RV also with slight systolic function impairment and apparent asymmetries in the segmental contractility of the inferior wall.
The patient was referred for cardiac magnetic resonance imaging (MRI) (Figure 1 ), which showed a slightly dilated LV (end-diastolic index volume of 107 mL/m 2 ), with ejection fraction of 44%; and a slightly dilated RV (enddiastolic index volume of 109 mL/m 2 ) with an ejection fraction of 39%, with evident dyskinetic areas on the free and diaphragmatic walls (in systole and diastole). There were also extensive areas of late enhancement (fibrosis) on the RV free wall (particularly at the third basal level), as well as on the LV interventricular septum and anterolateral wall, with a mid-myocardial distribution. No areas of adipocyte infiltration were observed in the fat suppression sequences. 
(E and F) Gradient echo images -inversion recovery, 10 minutes after gadolinium injection: late enhancement areas (arrows) are visualized on the right ventricular free wall, interventricular septum and left ventricular anterolateral wall, with non-ischemic distribution (mid-myocardial).
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Case Report
The presence of arrhythmogenic cardiomyopathy with biventricular involvement was admitted as the definitive diagnosis. The documentation of several episodes of nonsustained ventricular tachycardia in this context, with biventricular dysfunction, was the reason the patient was referred to receive an implantable cardioverter defibrillator (ICD).
Discussion
Although most patients with ARVD are asymptomatic, palpitations and syncope are common presenting symptoms. 2 A high level of suspicion is essential in cases where these symptoms are related to frequent premature ventricular contractions or VT episodes (sometimes asymptomatic ones), usually with the LBBB configuration (right ventricular origin) and superior axis. 4, 5 The classical diagnosis requires the histological evidence of myocardial replacement by fibrous or fibroadipose tissue, predominantly in the RV; 3.6 however, in the clinical context, the revised diagnostic criteria of the 2010 Task Force are applied. 5 The definitive diagnosis is based on the presence of two major criteria; one major criterion and two minor criteria; or four minor criteria from six different categories: global or regional structural changes, depolarization abnormalities, repolarization abnormalities, arrhythmias, histological findings, family history/genetic study (Chart 1).
Our case is noteworthy due to the presence of nonsustained VT, premature ventricular contractions with complete LBBB and superior axis pattern, as well as evidence of right ventricular dilatation and dysfunction associated with asymmetry/dyssynchrony of the RV free wall (Figure 1 , arrow heads), with two major criteria being met -a definitive diagnosis according to the revised 2010 Task Force criteria. The presence of concomitant left ventricular dysfunction and late enhancement Right ventricular ejection fraction > 40% and ≤ 45%
Histological characterization of the ventricular wall
Major -Residual myocytes <60% in the morphometric analysis (or <50% by estimation) with fibrous replacement of the right ventricular free wall in more than one sample, with or without adipose replacement in myocardial biopsy
Minor -60-75% of residual myocytes in the morphometric analysis (or 50-65% by estimation) with fibrous replacement of right ventricular free wall in more than one sample, with or without adipose replacement in myocardial biopsy
Ventricular repolarization alterations
Major -Inverted T waves in V1, V2 or V3 in individuals aged > 14 years in the absence of complete RBBB with QRS ≥ 120 ms
Minor -Inverted T waves in V1 and V2 in individuals aged > 14 years in the absence of complete RBBB with QRS ≥ 120 ms or in V4,
V5 or V6
Inverted T waves in V1, V2, V3 and V4 in subjects aged > 14 years in the presence of complete RBBB with QRS ≥ 120 ms Force criteria is difficult -Sudden cardiac death (age < 35 years) due to suspected ARVD in first-degree relative -ARVD confirmed by histopathology or according to the current Task Force criteria in second-degree relative * A pathogenic mutation is understood as a DNA change associated with ARVD, which alters or is expected to alter a coded protein, not being observed or being rare in a control population without ARVD, and which alters or is predicted to alter the protein function or structure, or that has shown an association with the phenotype of the pathology in a family tree. RVOT Case Report not restricted to the RV (Figure 1, arrows) is a finding compatible with biventricular involvement in the context of this cardiomyopathy.
Cont. chart 1 -Revised 2010 Task Force Criteria for the Diagnosis of Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy (ARVD)
Conduction/depolarization alterations
Major
It is important to emphasize that these diagnostic criteria refer to the ARVD, with or without LV involvement. However, LV involvement has been increasingly described, because of the development of several complementary diagnostic means, such as the cardiac MRI. 7 It is worth mentioning that, in some series, biventricular involvement reaches 70%. 5 This case is noteworthy not only for the presence of biventricular dilatation and dysfunction, but also for the obvious presence of late enhancement with a nonischemic pattern in both ventricles; this last finding has a sensitivity of 66% and a specificity of 100% for the diagnosis of this entity. 8 Particularly relevant is the use of the late enhancement criterion for the supposed evaluation of the LV involvement extent in some published series and case reports, when it does not integrate the current Task Force diagnostic items. 9 In fact,
